The Senate Judiciary Committee approved two bipartisan bills on February 11, 2016 that are intended to address abuse of opioid and other controlled substances and clarify the regulation of controlled substances. First, S. 524, the Comprehensive Addiction and Recovery Act of 2015, includes a wide range of prevention, education, law enforcement, treatment, and recovery provisions, including expanded first responder access to the overdose-reversal drug naloxone, expanded disposal sites for unwanted prescription medications, new evidence-based opioid treatment and intervention programs, and stronger prescription drug diversion monitoring programs. Second, S. 483, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015, would clarify the standards an applicant to manufacture or distribute controlled substances must meet in order to obtain a Controlled Substances Act (CSA) registration, and the circumstances under which such a registration may be suspended.